# Transcranial Static Magnetic Stimulation (tSMS) and Potential Theranostic Biomarkers in Amyotrophic Lateral Sclerosis.

> **NCT06834269** · NA · RECRUITING · sponsor: **Campus Bio-Medico University** · enrollment: 60 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis (ALS)

## Interventions

- **DEVICE:** Transcranial magnetic stimulation (tSMS)

## Key facts

- **NCT ID:** NCT06834269
- **Lead sponsor:** Campus Bio-Medico University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-02
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06834269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06834269, "Transcranial Static Magnetic Stimulation (tSMS) and Potential Theranostic Biomarkers in Amyotrophic Lateral Sclerosis.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06834269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
